XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 151 filers reported holding XENON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,320 | -11.3% | 2,000 | 0.0% | 0.01% | -16.7% |
| Q2 2023 | $77,000 | +7.6% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $71,580 | -9.2% | 2,000 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $78,860 | +9.5% | 2,000 | 0.0% | 0.01% | -14.3% |
| Q3 2022 | $72,000 | +18.0% | 2,000 | 0.0% | 0.01% | +40.0% |
| Q2 2022 | $61,000 | 0.0% | 2,000 | 0.0% | 0.01% | +25.0% |
| Q1 2022 | $61,000 | -1.6% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $62,000 | +100.0% | 2,000 | 0.0% | 0.00% | +100.0% |
| Q3 2021 | $31,000 | -16.2% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $37,000 | +2.8% | 2,000 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $36,000 | +16.1% | 2,000 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $31,000 | +40.9% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $22,000 | -12.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $25,000 | +8.7% | 2,000 | 0.0% | 0.00% | -33.3% |
| Q1 2020 | $23,000 | -11.5% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $26,000 | +188.9% | 2,000 | +100.0% | 0.00% | +50.0% |
| Q3 2019 | $9,000 | -55.0% | 1,000 | -50.0% | 0.00% | 0.0% |
| Q2 2019 | $20,000 | +100.0% | 2,000 | +100.0% | 0.00% | +100.0% |
| Q1 2019 | $10,000 | – | 1,000 | – | 0.00% | – |
| Q4 2018 | $0 | – | 0 | – | 0.00% | – |
| Q3 2018 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 1,594,932 | $57,577,000 | 9.26% |
| GREAT POINT PARTNERS LLC | 850,000 | $30,685,000 | 7.39% |
| ACUTA CAPITAL PARTNERS, LLC | 272,500 | $9,837,000 | 4.24% |
| DAFNA Capital Management LLC | 375,223 | $13,546,000 | 3.64% |
| Redmile Group, LLC | 2,370,614 | $85,579,000 | 3.32% |
| Avoro Capital Advisors LLC | 4,900,000 | $176,890,000 | 3.27% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 245,992 | $8,880,000 | 3.00% |
| Nan Fung Group Holdings Ltd | 114,380 | $4,129,000 | 2.64% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,504,020 | $162,595,000 | 2.46% |
| Parkman Healthcare Partners LLC | 222,597 | $8,036,000 | 2.28% |